brentuximab vedotin
takeda,seagen
['t-cell lymphoma', 'hodgkin', 'irene', 'brentuximab', 'lymphoma', 'lymsm', 'imab ']
hsp cd30 #cartcell in hodgkin #lymsm showed feasibility and tolerability, looking forward to more results, interesting manufacturing in 10 days #ash22 
A hematologist @MoffittNews with interest in #lymsm. Tweets are not endorsements, and not medical advice.